Skip to main content
SOMNOMED LIMITED logo

SOMNOMED LIMITED — Investor Relations & Filings

Ticker · SOM ISIN · AU000000SOM1 LEI · 529900NFR8QFOLJGP577 ASX Manufacturing
Open in API
Filings indexed 982 across all filing types
Latest filing 2025-08-27 Annual Report
Country AU Australia
Listing ASX SOM

About SOMNOMED LIMITED

https://somnomed.com

SomnoMed Limited specializes in the development and manufacture of diagnostic and treatment solutions for sleep-related breathing disorders, primarily obstructive sleep apnea (OSA). The company is recognized for its Continuous Open Airway Therapy (COAT), which utilizes custom-fitted oral appliances to maintain an open airway during sleep. Its flagship product line, SomnoDent, offers a range of mandibular advancement devices designed to improve patient compliance and comfort compared to traditional continuous positive airway pressure (CPAP) therapy. SomnoMed focuses on clinical research and technological innovation to provide effective, non-invasive alternatives for patients suffering from mild to moderate OSA and snoring. The company serves a global market, collaborating with sleep dentists and physicians to deliver personalized treatment options that enhance long-term health outcomes and quality of life for individuals with sleep-disordered breathing.

Recent filings

Filing Released Lang Actions
Full year results announcement FY25 3 pages 460.7KB
Annual Report Classification · 95% confidence The document is titled 'SomnoMed FY25 Full Year Results' and provides detailed financial results for the fiscal year ended 30 June 2025. It includes revenue, EBITDA, cash flow, regional performance, operational highlights, and outlook guidance for FY26. The content is comprehensive and contains substantive financial data and analysis for the full fiscal year. There is no indication that this is merely an announcement of a report or a certification. The document fits the definition of an Annual Report (10-K) or equivalent full-year financial report. Given the detailed financial review and full year coverage, the appropriate classification is Annual Report (10-K). FY 2025
2025-08-27 English
Investor presentation 21 pages 1.2MB
Investor Presentation Classification · 95% confidence The document is titled 'Investor Presentation Full Year 2025 Results August 2025' and contains detailed financial data, operational updates, and outlook information. It includes revenue, EBITDA, cash flow summaries, balance sheet data, and strategic highlights. The content is structured as a presentation aimed at investors, focusing on financial performance, operational progress, and future outlook. It is not a full annual report (10-K), nor is it a brief earnings release or a regulatory filing. The presence of slides, forward-looking statements, and summary financials aligns with the definition of an Investor Presentation (IP). The document length (15,000 characters) and detailed financial content support this classification with high confidence.
2025-08-27 English
Appendix 4G 14 pages 552.9KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations' and references ASX Listing Rules 4.7.3 and 4.10.3. It is a completed Appendix 4G form, which is a key to corporate governance disclosures and a verification tool for compliance with ASX Listing Rule 4.10.3. The document includes detailed checkboxes indicating whether the company has followed specific corporate governance recommendations and where disclosures can be found (e.g., corporate governance statement on the website). It explicitly states that the Appendix 4G is not a substitute for the corporate governance statement but is lodged with ASX alongside the annual report. The document is not the annual report itself, nor is it a management report or governance information report, but a regulatory filing required by ASX to confirm governance disclosures. The document length (15,000 characters) and content indicate it is a formal regulatory filing rather than a brief announcement or a full report. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2025-08-27 English
Corporate Governance Statement 20 pages 708.1KB
Governance Information Classification · 100% confidence The document is titled 'Corporate Governance Statement' and references compliance with the Australian Securities Exchange (ASX) Corporate Governance Principles and Recommendations. It discusses the board's roles, responsibilities, diversity policies, director appointment processes, and board performance evaluations. It is explicitly stated to be included in the Company's Annual Report pursuant to ASX Listing Rule 4.10.3. The content focuses on governance practices rather than financial results or other report types. The document length is substantial (15,000 characters), indicating it is the full statement, not just an announcement. Therefore, this document fits the category of Governance Information (CGR).
2025-08-27 English
FY25 Financial Results release date and webinar details 1
Investor Presentation Classification · 95% confidence The document is an announcement dated 7th August 2025 about the upcoming release of SomnoMed's FY25 Financial Results and Investor Presentation scheduled for 28th August 2025. It includes details about a webinar and Q&A session with company executives. The text does not contain actual financial data or the full report but rather informs investors about the timing and access to the presentation and results. The document length is short (1894 characters) and serves as a notice rather than the report itself. Therefore, it fits the category of an Investor Presentation announcement (IP).
2025-08-06 English
Application for quotation of securities - SOM 7 pages 22.5KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and details the issuance and quotation of securities resulting from the exercise of options or conversion of convertible securities. It includes specifics such as the number of securities, issue dates, and whether the securities are to be quoted on the ASX. This type of document is a formal announcement related to changes in the company's capital structure, specifically the quotation of new securities following option exercises. It is not a financial report, earnings release, or management discussion, but rather a capital/financing update. Therefore, the appropriate classification is 'Capital/Financing Update' (CAP). The document length and detail support a confident classification.
2025-08-05 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.